[The no-need-to-see process for adrenal incidentalomas]

Area of Science:

• Endocrinology
• Radiology
• Oncology

Background:

• Adrenal incidentalomas (AI) are frequently discovered due to advances in medical imaging.
• Current guidelines necessitate extensive investigation for hormonal hypersecretion and malignancy, straining healthcare resources.
• The
• no-need-to-see
• approach aims to streamline clinical assessment based on diagnostic test outcomes.

Purpose of the Study:

• To review the predictive values of imaging and laboratory tests for adrenal incidentalomas.
• To evaluate the utility of diagnostic testing in managing AI and preventing over-medicalization.

Main Methods:

• Systematic review of existing literature on adrenal incidentaloma diagnosis.
• Analysis of predictive values (sensitivity, specificity, PPV, NPV) of various imaging modalities and biochemical tests.
• Assessment of the clinical impact of the
• no-need-to-see
• strategy.

Main Results:

• Imaging and paraclinical tests possess significant predictive values in evaluating adrenal incidentalomas.
• Normal test results in patients without known extra-adrenal malignancy effectively exclude clinically significant adrenal disease.
• The
• no-need-to-see
• process can identify individuals requiring further clinical assessment.

Conclusions:

• Normal diagnostic workup for adrenal incidentalomas can safely rule out hormonal hypersecretion and malignancy in most cases.
• Implementing a strategy based on predictive values of tests can optimize healthcare resource utilization.
• Further validation of the
• no-need-to-see
• approach may reduce unnecessary patient medicalization.